| Financial Year |
March 31 2023 |
| Monetary Funds |
571,805,584.39 |
| Held-for-trading Financial Assets |
58,677.81 |
| Notes Receivable |
15,504,799.83 |
| Accounts Receivable |
129,039,474.20 |
| Advances to Suppliers |
172,755,562.10 |
| Other Receivables |
56,545,704.79 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
686,141,793.55 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
8,530,000.00 |
| Other Current Assets |
27,388,785.02 |
| Total Current Assets |
1,781,450,962.21 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
895,128.54 |
| Long-term Equity Investment |
60,221,986.26 |
| Investment Properties |
67,065,191.00 |
| Fixed Assetes |
579,314,375.57 |
| Under-construction Projects |
31,048,225.76 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
26,017,261.74 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
41,900,711.87 |
| Deferred Income Tax Assets |
19,408,482.03 |
| Other Non-Current Assets |
12,618,723.12 |
| Sub-Total of Non-Current Assets |
914,719,823.05 |
| Total Assets |
2,696,170,785.26 |
| Short-Term Loans |
359,762,962.18 |
| Trading Financial liabilities |
-- |
| Notes Payable |
31,017,281.82 |
| Accounts Payable |
174,018,377.24 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
8,754,295.22 |
| Taxes Payable |
16,487,209.17 |
| Interest Payable |
23,161,202.69 |
| Dividend Payable |
-- |
| Other payables |
250,163,565.33 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
23,109,934.61 |
| Other Current Liabilities |
7,699,067.82 |
| Sub-Total of Current Liabilities |
930,236,292.01 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
5,662,250.02 |
| Deferred Income Tax Liabilities |
20,375,418.47 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
60,720,200.85 |
| Total Liabilities |
990,956,492.86 |
| Paid-In Capital(Or Share Stock) |
640,205,880.00 |
| Capital Surplus |
1,385,598,164.97 |
| Surplus Reserve |
67,948,162.86 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-389,943,507.84 |
| Minority Stockholder's Interest |
1,405,592.41 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,703,808,699.99 |
| Owner's Equity（Stockholder's Equity） |
1,705,214,292.40 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,696,170,785.26 |
